Archive for May 11th, 2011

ALTH collaboration + SCMP ARNA MYRX INFI pipeline updates

May 11, 2011 No Comments by

Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP) maintained previous guidance that they hope to complete enrollment in their third Phase 3 clinical trial for lubiprostone for Opioid-induced bowel dysfunction during 3Q 2011. They also hope to file a Marketing Approval Application (MAA) for lubiprostone for the treatment of Chronic idiopathic constipation in the United Kingdom by the […]

Daily News Read more